integrin αvβ3 Search Results


90
Cosmo Bio USA fitc-labeled antibody against αvβ3 integrin
Fitc Labeled Antibody Against αvβ3 Integrin, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc-labeled antibody against αvβ3 integrin/product/Cosmo Bio USA
Average 90 stars, based on 1 article reviews
fitc-labeled antibody against αvβ3 integrin - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
YO Proteins purified human αvβ3 integrin protein
25HC interacts with α5β1 and <t>αvβ3</t> integrins. a , b Biotinylation reactions were performed in the presence of either 25HC or DMSO (control). Cell lysates collected from BMDMs ( a ) or RAW 264.7 macrophages ( b ) incubated with biotinylated 25HC (biotin-25HC) or DMSO at 4 °C were precipitated (PPT) with avidin–agarose and subsequently immuno-blotted (IB) with either α5 <t>integrin</t> ( a ) or αv integrin ( b ) antibody. Total lysates were also blotted with α5 integrin ( a ), αv integrin ( b ), and actin ( a , b ) antibodies. c , d Biotin-25HC and DMSO (control) were incubated (PPT; precipitated) with avidin–agarose beads. 25HC conjugated beads were then incubated either with purified α5β1 integrin ( c ) or αvβ3 integrin ( d ). The avidin–agarose bound complex was subsequently immuno-blotted with either α5 integrin ( c ) or αv integrin ( d ) antibody. e , f Protein G-agarose beads were conjugated with either control IgG or antibody (Ab) specific for α5 integrin ( e ) and αv integrin ( f ). The beads were then incubated with either purified α5β1 integrin ( e ) or αvβ3 integrin ( f ) protein. Control beads (control IgG + purified integrin protein) and integrin protein bound beads (integrin-specific antibody + purified integrin protein) was incubated with tritiated 3 H-25HC. Bead-bound radioactivity (count per minute; CPM) was measured by scintillation counter. g Cell lysate collected from RAW 264.7 macrophages incubated with biotin-25HC, biotinylated 27-hydroxycholesterol (biotin-27HC), biotinylated 4β-hydroxycholesterol (biotin-4βHC) or DMSO (control) at 4 °C was precipitated (PPT) with avidin–agarose and subsequently immuno-blotted with α5 integrin antibody. Total cell lysate was also blotted with α5 integrin and β-actin antibodies. h Surface plasmon resonance (SPR) analyses were performed by injecting increasing concentrations of 25HC (16 nM, 40 nM, 160 nM, 640 nM, 1.6 µM) into both the αvβ3 integrin-immobilized and control surface of the CM5 chips. Each background-corrected sensorgram is a representative of replicate runs. i Binding of radioactive 3 H-25HC to immobilized αvβ3 integrin protein in the presence or absence of purified chemokine domain of fractalkine protein was assessed as described in the “methods” section. Immunoblot images are representative from three independent experiments. The radioactive values (mean ± standard deviation) are representative from two independent experiments. * p ≤ 0.05 using a Student’s t -test
Purified Human αvβ3 Integrin Protein, supplied by YO Proteins, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/purified human αvβ3 integrin protein/product/YO Proteins
Average 90 stars, based on 1 article reviews
purified human αvβ3 integrin protein - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Kringle Pharma Inc αvβ3 integrin
Extracellular Matrix derived Endogenous angioinhibitors and their mode of action.
αvβ3 Integrin, supplied by Kringle Pharma Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/αvβ3 integrin/product/Kringle Pharma Inc
Average 90 stars, based on 1 article reviews
αvβ3 integrin - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Hubner GmbH integrin αvβ3
Extracellular Matrix derived Endogenous angioinhibitors and their mode of action.
Integrin αvβ3, supplied by Hubner GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/integrin αvβ3/product/Hubner GmbH
Average 90 stars, based on 1 article reviews
integrin αvβ3 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc competitive binding enzyme-linked immunosorbent assays (elisas) for integrins αvβ6 and αvβ3
Extracellular Matrix derived Endogenous angioinhibitors and their mode of action.
Competitive Binding Enzyme Linked Immunosorbent Assays (Elisas) For Integrins αvβ6 And αvβ3, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/competitive binding enzyme-linked immunosorbent assays (elisas) for integrins αvβ6 and αvβ3/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
competitive binding enzyme-linked immunosorbent assays (elisas) for integrins αvβ6 and αvβ3 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
AnaSpec cyclo (rgdfc) αvβ3 integrin-binding peptide (rgd)
T3 induces ISG expression using non-genomic mechanisms involving <t>integrin</t> <t>αVβ3</t> binding and activation of PLC–PI3K–AKT pathways. (a) HEK293FT cells were transfected with 1.5 µg of empty vector or cTHRα plasmid and protein extracts were processed for Western blot using Abs to THRα/β. Non-specific (NS) band is shown for equal loading. (b). HEK293FT cells were transfected with 1.0 μg of TATADR4-Luc in the presence or absence of 1.5 µg of empty vector or cTHRα plasmid. After 24 h of transfection, cells were treated with 75 µM T3 and harvested 16 h later for luciferase activity measurement. ** P < 0.01. NS: not significant. (c) HEK293FT cell were transfected with 1.0 µg of empty vector or cTHRα plasmid for 24 h. Cells were then treated with DMSO or 75 µM T3 for 16 h in the presence or absence of Poly IC. (d) 50 ng of IFIT-Promoter-Luc or 100 ng ISRE-Luc plasmids were transfected in HEK293FT cells followed by treatment with Poly IC in the presence or absence of DMSO or 75 µM T3. Cells were harvested and luciferase activity was measured. ** P < 0.01. (e) HEK293FT cells were treated with T3 (75 µM) or Poly IC either alone or in combination with each other in the presence of either DMSO or LY294002 (5 µM), U73122 (10 µM), or U0126 (5 µM) for 16 h. (f) HEK293FT cells were treated with T3 (75 µM) for indicated time periods. Proteins extracts were analyzed by Western blot using Abs to total AKT and phospho-AKT. (g) HEK293FT cells were treated for 16 h with DMSO or 75 µM T3 in the presence or absence of Poly IC and 50 µg/ml <t>RGD</t> peptide or a control peptide. RNA was isolated from the cell pellets (c, e, and g) and the expression of IFIT3 quantitated by real-time RT-PCR as described in the Methods section. All the data presented are in comparison to DMSO control groups. ** P < 0.01. NS: not significant.
Cyclo (Rgdfc) αvβ3 Integrin Binding Peptide (Rgd), supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cyclo (rgdfc) αvβ3 integrin-binding peptide (rgd)/product/AnaSpec
Average 90 stars, based on 1 article reviews
cyclo (rgdfc) αvβ3 integrin-binding peptide (rgd) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
NanoMed Pharmaceuticals ultrasmallsuperparamagnetic iron oxide targeting integrin αvβ3
T3 induces ISG expression using non-genomic mechanisms involving <t>integrin</t> <t>αVβ3</t> binding and activation of PLC–PI3K–AKT pathways. (a) HEK293FT cells were transfected with 1.5 µg of empty vector or cTHRα plasmid and protein extracts were processed for Western blot using Abs to THRα/β. Non-specific (NS) band is shown for equal loading. (b). HEK293FT cells were transfected with 1.0 μg of TATADR4-Luc in the presence or absence of 1.5 µg of empty vector or cTHRα plasmid. After 24 h of transfection, cells were treated with 75 µM T3 and harvested 16 h later for luciferase activity measurement. ** P < 0.01. NS: not significant. (c) HEK293FT cell were transfected with 1.0 µg of empty vector or cTHRα plasmid for 24 h. Cells were then treated with DMSO or 75 µM T3 for 16 h in the presence or absence of Poly IC. (d) 50 ng of IFIT-Promoter-Luc or 100 ng ISRE-Luc plasmids were transfected in HEK293FT cells followed by treatment with Poly IC in the presence or absence of DMSO or 75 µM T3. Cells were harvested and luciferase activity was measured. ** P < 0.01. (e) HEK293FT cells were treated with T3 (75 µM) or Poly IC either alone or in combination with each other in the presence of either DMSO or LY294002 (5 µM), U73122 (10 µM), or U0126 (5 µM) for 16 h. (f) HEK293FT cells were treated with T3 (75 µM) for indicated time periods. Proteins extracts were analyzed by Western blot using Abs to total AKT and phospho-AKT. (g) HEK293FT cells were treated for 16 h with DMSO or 75 µM T3 in the presence or absence of Poly IC and 50 µg/ml <t>RGD</t> peptide or a control peptide. RNA was isolated from the cell pellets (c, e, and g) and the expression of IFIT3 quantitated by real-time RT-PCR as described in the Methods section. All the data presented are in comparison to DMSO control groups. ** P < 0.01. NS: not significant.
Ultrasmallsuperparamagnetic Iron Oxide Targeting Integrin αvβ3, supplied by NanoMed Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ultrasmallsuperparamagnetic iron oxide targeting integrin αvβ3/product/NanoMed Pharmaceuticals
Average 90 stars, based on 1 article reviews
ultrasmallsuperparamagnetic iron oxide targeting integrin αvβ3 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Stouffer Industries protein complexes involving αvβ3 integrins, nonmuscle myosin heavy chain-a and focal adhesion kinase
T3 induces ISG expression using non-genomic mechanisms involving <t>integrin</t> <t>αVβ3</t> binding and activation of PLC–PI3K–AKT pathways. (a) HEK293FT cells were transfected with 1.5 µg of empty vector or cTHRα plasmid and protein extracts were processed for Western blot using Abs to THRα/β. Non-specific (NS) band is shown for equal loading. (b). HEK293FT cells were transfected with 1.0 μg of TATADR4-Luc in the presence or absence of 1.5 µg of empty vector or cTHRα plasmid. After 24 h of transfection, cells were treated with 75 µM T3 and harvested 16 h later for luciferase activity measurement. ** P < 0.01. NS: not significant. (c) HEK293FT cell were transfected with 1.0 µg of empty vector or cTHRα plasmid for 24 h. Cells were then treated with DMSO or 75 µM T3 for 16 h in the presence or absence of Poly IC. (d) 50 ng of IFIT-Promoter-Luc or 100 ng ISRE-Luc plasmids were transfected in HEK293FT cells followed by treatment with Poly IC in the presence or absence of DMSO or 75 µM T3. Cells were harvested and luciferase activity was measured. ** P < 0.01. (e) HEK293FT cells were treated with T3 (75 µM) or Poly IC either alone or in combination with each other in the presence of either DMSO or LY294002 (5 µM), U73122 (10 µM), or U0126 (5 µM) for 16 h. (f) HEK293FT cells were treated with T3 (75 µM) for indicated time periods. Proteins extracts were analyzed by Western blot using Abs to total AKT and phospho-AKT. (g) HEK293FT cells were treated for 16 h with DMSO or 75 µM T3 in the presence or absence of Poly IC and 50 µg/ml <t>RGD</t> peptide or a control peptide. RNA was isolated from the cell pellets (c, e, and g) and the expression of IFIT3 quantitated by real-time RT-PCR as described in the Methods section. All the data presented are in comparison to DMSO control groups. ** P < 0.01. NS: not significant.
Protein Complexes Involving αvβ3 Integrins, Nonmuscle Myosin Heavy Chain A And Focal Adhesion Kinase, supplied by Stouffer Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protein complexes involving αvβ3 integrins, nonmuscle myosin heavy chain-a and focal adhesion kinase/product/Stouffer Industries
Average 90 stars, based on 1 article reviews
protein complexes involving αvβ3 integrins, nonmuscle myosin heavy chain-a and focal adhesion kinase - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Peptido GmbH peptido-mimetic αvβ3 integrin-binding ligand
T3 induces ISG expression using non-genomic mechanisms involving <t>integrin</t> <t>αVβ3</t> binding and activation of PLC–PI3K–AKT pathways. (a) HEK293FT cells were transfected with 1.5 µg of empty vector or cTHRα plasmid and protein extracts were processed for Western blot using Abs to THRα/β. Non-specific (NS) band is shown for equal loading. (b). HEK293FT cells were transfected with 1.0 μg of TATADR4-Luc in the presence or absence of 1.5 µg of empty vector or cTHRα plasmid. After 24 h of transfection, cells were treated with 75 µM T3 and harvested 16 h later for luciferase activity measurement. ** P < 0.01. NS: not significant. (c) HEK293FT cell were transfected with 1.0 µg of empty vector or cTHRα plasmid for 24 h. Cells were then treated with DMSO or 75 µM T3 for 16 h in the presence or absence of Poly IC. (d) 50 ng of IFIT-Promoter-Luc or 100 ng ISRE-Luc plasmids were transfected in HEK293FT cells followed by treatment with Poly IC in the presence or absence of DMSO or 75 µM T3. Cells were harvested and luciferase activity was measured. ** P < 0.01. (e) HEK293FT cells were treated with T3 (75 µM) or Poly IC either alone or in combination with each other in the presence of either DMSO or LY294002 (5 µM), U73122 (10 µM), or U0126 (5 µM) for 16 h. (f) HEK293FT cells were treated with T3 (75 µM) for indicated time periods. Proteins extracts were analyzed by Western blot using Abs to total AKT and phospho-AKT. (g) HEK293FT cells were treated for 16 h with DMSO or 75 µM T3 in the presence or absence of Poly IC and 50 µg/ml <t>RGD</t> peptide or a control peptide. RNA was isolated from the cell pellets (c, e, and g) and the expression of IFIT3 quantitated by real-time RT-PCR as described in the Methods section. All the data presented are in comparison to DMSO control groups. ** P < 0.01. NS: not significant.
Peptido Mimetic αvβ3 Integrin Binding Ligand, supplied by Peptido GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptido-mimetic αvβ3 integrin-binding ligand/product/Peptido GmbH
Average 90 stars, based on 1 article reviews
peptido-mimetic αvβ3 integrin-binding ligand - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Biochemie GmbH integrin αvβ3
T3 induces ISG expression using non-genomic mechanisms involving <t>integrin</t> <t>αVβ3</t> binding and activation of PLC–PI3K–AKT pathways. (a) HEK293FT cells were transfected with 1.5 µg of empty vector or cTHRα plasmid and protein extracts were processed for Western blot using Abs to THRα/β. Non-specific (NS) band is shown for equal loading. (b). HEK293FT cells were transfected with 1.0 μg of TATADR4-Luc in the presence or absence of 1.5 µg of empty vector or cTHRα plasmid. After 24 h of transfection, cells were treated with 75 µM T3 and harvested 16 h later for luciferase activity measurement. ** P < 0.01. NS: not significant. (c) HEK293FT cell were transfected with 1.0 µg of empty vector or cTHRα plasmid for 24 h. Cells were then treated with DMSO or 75 µM T3 for 16 h in the presence or absence of Poly IC. (d) 50 ng of IFIT-Promoter-Luc or 100 ng ISRE-Luc plasmids were transfected in HEK293FT cells followed by treatment with Poly IC in the presence or absence of DMSO or 75 µM T3. Cells were harvested and luciferase activity was measured. ** P < 0.01. (e) HEK293FT cells were treated with T3 (75 µM) or Poly IC either alone or in combination with each other in the presence of either DMSO or LY294002 (5 µM), U73122 (10 µM), or U0126 (5 µM) for 16 h. (f) HEK293FT cells were treated with T3 (75 µM) for indicated time periods. Proteins extracts were analyzed by Western blot using Abs to total AKT and phospho-AKT. (g) HEK293FT cells were treated for 16 h with DMSO or 75 µM T3 in the presence or absence of Poly IC and 50 µg/ml <t>RGD</t> peptide or a control peptide. RNA was isolated from the cell pellets (c, e, and g) and the expression of IFIT3 quantitated by real-time RT-PCR as described in the Methods section. All the data presented are in comparison to DMSO control groups. ** P < 0.01. NS: not significant.
Integrin αvβ3, supplied by Biochemie GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/integrin αvβ3/product/Biochemie GmbH
Average 90 stars, based on 1 article reviews
integrin αvβ3 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Rocha labs integrin αvβ3
<t>Integrin</t> <t>αVβ3</t> is upregulated in OPLL. a Typical preoperative CT and image of a patient with cervical OPLL (the red square at the left indicates OPLL of the cervical spine) and postoperative X-ray image indicating anterior en bloc resection of the cervical ossified posterior longitudinal ligament (the blue square at the right). b RNA-seq visualized by heatmap analysis. c GSEA plots illustrating upregulation of ECM receptor signaling pathway in LFs derived from patients with OPLL and non-OPLL. d Integrin subfamily molecule expression levels using the RNA-seq sequencing results visualized by heatmap analysis. e Relative mRNA expression levels of Integrin subfamily molecule. f The expression of integrin αVβ3 was detected by western blot. g HE staining, immunohistochemical analysis of OCN and integrin αVβ3, and immunofluorescence analysis of CD31 in ligament tissues from patients with OPLL and non-OPLL patients. h Quantitative analysis of OCN-positive cells in g. n = 3 per group. i Quantitative analysis of integrin αVβ3-positive cells in g. n = 3 per group. j Quantitative analysis of CD31-positive cells in g, n = 3 per group. k Quantitative analysis of integrin αVβ3 by western blot. n = 3 per group. All experimental data are presented as the mean value ± SD. Student’s t-test used in ( h ), ( i ), ( j ), and ( k ). * p < 0.05, ** p < 0.01, *** p < 0.001
Integrin αvβ3, supplied by Rocha labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/integrin αvβ3/product/Rocha labs
Average 90 stars, based on 1 article reviews
integrin αvβ3 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Centocor Inc a375s.2 human melanoma cell line
<t>Integrin</t> <t>αVβ3</t> is upregulated in OPLL. a Typical preoperative CT and image of a patient with cervical OPLL (the red square at the left indicates OPLL of the cervical spine) and postoperative X-ray image indicating anterior en bloc resection of the cervical ossified posterior longitudinal ligament (the blue square at the right). b RNA-seq visualized by heatmap analysis. c GSEA plots illustrating upregulation of ECM receptor signaling pathway in LFs derived from patients with OPLL and non-OPLL. d Integrin subfamily molecule expression levels using the RNA-seq sequencing results visualized by heatmap analysis. e Relative mRNA expression levels of Integrin subfamily molecule. f The expression of integrin αVβ3 was detected by western blot. g HE staining, immunohistochemical analysis of OCN and integrin αVβ3, and immunofluorescence analysis of CD31 in ligament tissues from patients with OPLL and non-OPLL patients. h Quantitative analysis of OCN-positive cells in g. n = 3 per group. i Quantitative analysis of integrin αVβ3-positive cells in g. n = 3 per group. j Quantitative analysis of CD31-positive cells in g, n = 3 per group. k Quantitative analysis of integrin αVβ3 by western blot. n = 3 per group. All experimental data are presented as the mean value ± SD. Student’s t-test used in ( h ), ( i ), ( j ), and ( k ). * p < 0.05, ** p < 0.01, *** p < 0.001
A375s.2 Human Melanoma Cell Line, supplied by Centocor Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a375s.2 human melanoma cell line/product/Centocor Inc
Average 90 stars, based on 1 article reviews
a375s.2 human melanoma cell line - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


25HC interacts with α5β1 and αvβ3 integrins. a , b Biotinylation reactions were performed in the presence of either 25HC or DMSO (control). Cell lysates collected from BMDMs ( a ) or RAW 264.7 macrophages ( b ) incubated with biotinylated 25HC (biotin-25HC) or DMSO at 4 °C were precipitated (PPT) with avidin–agarose and subsequently immuno-blotted (IB) with either α5 integrin ( a ) or αv integrin ( b ) antibody. Total lysates were also blotted with α5 integrin ( a ), αv integrin ( b ), and actin ( a , b ) antibodies. c , d Biotin-25HC and DMSO (control) were incubated (PPT; precipitated) with avidin–agarose beads. 25HC conjugated beads were then incubated either with purified α5β1 integrin ( c ) or αvβ3 integrin ( d ). The avidin–agarose bound complex was subsequently immuno-blotted with either α5 integrin ( c ) or αv integrin ( d ) antibody. e , f Protein G-agarose beads were conjugated with either control IgG or antibody (Ab) specific for α5 integrin ( e ) and αv integrin ( f ). The beads were then incubated with either purified α5β1 integrin ( e ) or αvβ3 integrin ( f ) protein. Control beads (control IgG + purified integrin protein) and integrin protein bound beads (integrin-specific antibody + purified integrin protein) was incubated with tritiated 3 H-25HC. Bead-bound radioactivity (count per minute; CPM) was measured by scintillation counter. g Cell lysate collected from RAW 264.7 macrophages incubated with biotin-25HC, biotinylated 27-hydroxycholesterol (biotin-27HC), biotinylated 4β-hydroxycholesterol (biotin-4βHC) or DMSO (control) at 4 °C was precipitated (PPT) with avidin–agarose and subsequently immuno-blotted with α5 integrin antibody. Total cell lysate was also blotted with α5 integrin and β-actin antibodies. h Surface plasmon resonance (SPR) analyses were performed by injecting increasing concentrations of 25HC (16 nM, 40 nM, 160 nM, 640 nM, 1.6 µM) into both the αvβ3 integrin-immobilized and control surface of the CM5 chips. Each background-corrected sensorgram is a representative of replicate runs. i Binding of radioactive 3 H-25HC to immobilized αvβ3 integrin protein in the presence or absence of purified chemokine domain of fractalkine protein was assessed as described in the “methods” section. Immunoblot images are representative from three independent experiments. The radioactive values (mean ± standard deviation) are representative from two independent experiments. * p ≤ 0.05 using a Student’s t -test

Journal: Nature Communications

Article Title: Integrin activation by the lipid molecule 25-hydroxycholesterol induces a proinflammatory response

doi: 10.1038/s41467-019-09453-x

Figure Lengend Snippet: 25HC interacts with α5β1 and αvβ3 integrins. a , b Biotinylation reactions were performed in the presence of either 25HC or DMSO (control). Cell lysates collected from BMDMs ( a ) or RAW 264.7 macrophages ( b ) incubated with biotinylated 25HC (biotin-25HC) or DMSO at 4 °C were precipitated (PPT) with avidin–agarose and subsequently immuno-blotted (IB) with either α5 integrin ( a ) or αv integrin ( b ) antibody. Total lysates were also blotted with α5 integrin ( a ), αv integrin ( b ), and actin ( a , b ) antibodies. c , d Biotin-25HC and DMSO (control) were incubated (PPT; precipitated) with avidin–agarose beads. 25HC conjugated beads were then incubated either with purified α5β1 integrin ( c ) or αvβ3 integrin ( d ). The avidin–agarose bound complex was subsequently immuno-blotted with either α5 integrin ( c ) or αv integrin ( d ) antibody. e , f Protein G-agarose beads were conjugated with either control IgG or antibody (Ab) specific for α5 integrin ( e ) and αv integrin ( f ). The beads were then incubated with either purified α5β1 integrin ( e ) or αvβ3 integrin ( f ) protein. Control beads (control IgG + purified integrin protein) and integrin protein bound beads (integrin-specific antibody + purified integrin protein) was incubated with tritiated 3 H-25HC. Bead-bound radioactivity (count per minute; CPM) was measured by scintillation counter. g Cell lysate collected from RAW 264.7 macrophages incubated with biotin-25HC, biotinylated 27-hydroxycholesterol (biotin-27HC), biotinylated 4β-hydroxycholesterol (biotin-4βHC) or DMSO (control) at 4 °C was precipitated (PPT) with avidin–agarose and subsequently immuno-blotted with α5 integrin antibody. Total cell lysate was also blotted with α5 integrin and β-actin antibodies. h Surface plasmon resonance (SPR) analyses were performed by injecting increasing concentrations of 25HC (16 nM, 40 nM, 160 nM, 640 nM, 1.6 µM) into both the αvβ3 integrin-immobilized and control surface of the CM5 chips. Each background-corrected sensorgram is a representative of replicate runs. i Binding of radioactive 3 H-25HC to immobilized αvβ3 integrin protein in the presence or absence of purified chemokine domain of fractalkine protein was assessed as described in the “methods” section. Immunoblot images are representative from three independent experiments. The radioactive values (mean ± standard deviation) are representative from two independent experiments. * p ≤ 0.05 using a Student’s t -test

Article Snippet: Purified human αvβ3 integrin protein (Yo proteins AB, Huddinge, Sweden) was covalently immobilized on a flow cell of CM5 chip (carboxy-methylated dextran coated) in 10 mM sodium acetate buffer, pH 4.0, using EDC/NHS amine coupling chemistry at 25 °C.

Techniques: Incubation, Avidin-Biotin Assay, Purification, Radioactivity, SPR Assay, Binding Assay, Western Blot, Standard Deviation

Modeling identifies specific interactions between αvβ3 integrin and 25HC. a Ectodomain structure of αvβ3 integrin containing ‘RGD’’-binding site (site I) (blue) and site-II (red) residues highlighted by a layer of solvent molecule of radius 1.4 Å. The site-II-bound 25HC molecule is presented as a surface model in green and Mn 2+ ions from metal-ion-dependent ligand-binding site (MIDAS) and adjacent to MIDAS (ADMIDAS) sites of βI domain, β-propeller domain and genu knee region are presented in cyan. b Potential interacting residues for molecular recognition of αvβ3 integrin by 25HC were identified in a docking simulation. H-bonds are highlighted in dashed lines in red. c , d Ser399 of β-propeller (red), Ser162 (blue) and Ala263 (black) of βI domain make stable H-bond interactions with 3- and 25-hydroxyl groups of 25HC, respectively. The H-bond distances ( c ) and H-bond angles ( d ) are plotted against MD simulation time (200 ns). e The root-mean-square deviations (RMSD) measured for specificity-determining loop (SDL), α1- and α7 helices during the entire 200 ns long simulation. The SDL region undergoes significant conformational change (RMSD of ~6 Å) upon 25HC binding. f The conformational change in the SDL is accompanied by disruption of H-bond interaction between Tyr122-Thr182 residues, as well as change in the β-propeller blade that interacts with SDL. Movement of the regions from the beginning 0 ns (blue) to the end 200 ns (red) is indicated by arrows. g Correlation matrices (as heat maps) indicating correlated (red) or anti-correlated motions (blue) of α- and β-subunits of αvβ3 integrin in unbound and 25HC-bound states. h , i The distance between the amide NH of Q120 of the β-propeller domain and backbone carbonyl oxygen of P169 of the SDL. Breakage of this electrostatic interaction in the 25HC-bound protein (blue) during the simulation, around ~30 ns simulation causes significant increase in the distance, which remain intact in the unbound protein (magenta) during the entire 200 ns simulation time

Journal: Nature Communications

Article Title: Integrin activation by the lipid molecule 25-hydroxycholesterol induces a proinflammatory response

doi: 10.1038/s41467-019-09453-x

Figure Lengend Snippet: Modeling identifies specific interactions between αvβ3 integrin and 25HC. a Ectodomain structure of αvβ3 integrin containing ‘RGD’’-binding site (site I) (blue) and site-II (red) residues highlighted by a layer of solvent molecule of radius 1.4 Å. The site-II-bound 25HC molecule is presented as a surface model in green and Mn 2+ ions from metal-ion-dependent ligand-binding site (MIDAS) and adjacent to MIDAS (ADMIDAS) sites of βI domain, β-propeller domain and genu knee region are presented in cyan. b Potential interacting residues for molecular recognition of αvβ3 integrin by 25HC were identified in a docking simulation. H-bonds are highlighted in dashed lines in red. c , d Ser399 of β-propeller (red), Ser162 (blue) and Ala263 (black) of βI domain make stable H-bond interactions with 3- and 25-hydroxyl groups of 25HC, respectively. The H-bond distances ( c ) and H-bond angles ( d ) are plotted against MD simulation time (200 ns). e The root-mean-square deviations (RMSD) measured for specificity-determining loop (SDL), α1- and α7 helices during the entire 200 ns long simulation. The SDL region undergoes significant conformational change (RMSD of ~6 Å) upon 25HC binding. f The conformational change in the SDL is accompanied by disruption of H-bond interaction between Tyr122-Thr182 residues, as well as change in the β-propeller blade that interacts with SDL. Movement of the regions from the beginning 0 ns (blue) to the end 200 ns (red) is indicated by arrows. g Correlation matrices (as heat maps) indicating correlated (red) or anti-correlated motions (blue) of α- and β-subunits of αvβ3 integrin in unbound and 25HC-bound states. h , i The distance between the amide NH of Q120 of the β-propeller domain and backbone carbonyl oxygen of P169 of the SDL. Breakage of this electrostatic interaction in the 25HC-bound protein (blue) during the simulation, around ~30 ns simulation causes significant increase in the distance, which remain intact in the unbound protein (magenta) during the entire 200 ns simulation time

Article Snippet: Purified human αvβ3 integrin protein (Yo proteins AB, Huddinge, Sweden) was covalently immobilized on a flow cell of CM5 chip (carboxy-methylated dextran coated) in 10 mM sodium acetate buffer, pH 4.0, using EDC/NHS amine coupling chemistry at 25 °C.

Techniques: Binding Assay, Ligand Binding Assay

25HC activates αvβ3 integrin in epithelial cell focal adhesions and macrophage podosomes. a Human lung epithelial cells (A549 cells) or differentiated THP-1 macrophages were subjected to various treatments and immunostained as indicated. In untreated (UT) A549 and THP-1 cells (first row), αvβ3 integrin, immunostained using the antibody LM609, was present in paxillin-positive focal adhesions and podosomes, respectively. In contrast, active αvβ3 integrin staining, indicated using the antibody AP5 (second and third row), was found almost exclusively in cells treated for 2 h with 0.5 µM 25HC compared with DMSO-treated controls. Merged images show the co-localization of αvβ3 integrin (total or activated) with focal adhesions/podosomes. Bar, 10 µm. b Quantification of the number of focal adhesions (FAs) and AP5 + FAs in A549 cells (three experiments, >12 cells per experiment; n ≥ 30). c Quantification of the number of podosomes and AP5 + podosomes in THP-1 cells (three experiments, 25 cells per experiment; n ≥ 70). Two- and One-tailed Wilcoxon rank-sum tests were performed to evaluate differences between total and AP5 + FA/podosome counts, respectively. Graphs depict mean ± SEM. * p ≤ 0.05

Journal: Nature Communications

Article Title: Integrin activation by the lipid molecule 25-hydroxycholesterol induces a proinflammatory response

doi: 10.1038/s41467-019-09453-x

Figure Lengend Snippet: 25HC activates αvβ3 integrin in epithelial cell focal adhesions and macrophage podosomes. a Human lung epithelial cells (A549 cells) or differentiated THP-1 macrophages were subjected to various treatments and immunostained as indicated. In untreated (UT) A549 and THP-1 cells (first row), αvβ3 integrin, immunostained using the antibody LM609, was present in paxillin-positive focal adhesions and podosomes, respectively. In contrast, active αvβ3 integrin staining, indicated using the antibody AP5 (second and third row), was found almost exclusively in cells treated for 2 h with 0.5 µM 25HC compared with DMSO-treated controls. Merged images show the co-localization of αvβ3 integrin (total or activated) with focal adhesions/podosomes. Bar, 10 µm. b Quantification of the number of focal adhesions (FAs) and AP5 + FAs in A549 cells (three experiments, >12 cells per experiment; n ≥ 30). c Quantification of the number of podosomes and AP5 + podosomes in THP-1 cells (three experiments, 25 cells per experiment; n ≥ 70). Two- and One-tailed Wilcoxon rank-sum tests were performed to evaluate differences between total and AP5 + FA/podosome counts, respectively. Graphs depict mean ± SEM. * p ≤ 0.05

Article Snippet: Purified human αvβ3 integrin protein (Yo proteins AB, Huddinge, Sweden) was covalently immobilized on a flow cell of CM5 chip (carboxy-methylated dextran coated) in 10 mM sodium acetate buffer, pH 4.0, using EDC/NHS amine coupling chemistry at 25 °C.

Techniques: Staining, One-tailed Test

α5β1 and αvβ3 integrins regulate 25HC-mediated proinflammatory response. a , c – g α5β1 and αvβ3 integrin-deficient cells were treated with 50 µM 25HC for 8 h to evaluate NFκB activation and proinflammatory response. a TNF secretion from 25HC-treated NR-9456 macrophages in the presence of either control IgG or α5β1 integrin blocking antibody (Ab). b Western blot analyses of α5 integrin protein expression in THP-1 cells transfected with either control siRNA (con siRNA) or α5 integrin-specific siRNA (α5 siRNA). c RT-PCR analyses of TNF expression in 25HC-treated THP-1 cells transfected with either control siRNA (con siRNA) or α5 integrin-specific siRNA (α5 siRNA). d Western blot and densitometric analyses of phospho-IκB status in 25HC-treated wild-type (WT) and α5 integrin knockout (KO) HAP1 cells. e TNF secretion from 25HC-treated WT and β3 integrin-deficient (β3 +/− cells) BMDMs. f , g TNF ( f ) and IL-6 ( g ) secretion from 25HC-treated THP-1 macrophages in the presence of either control IgG or αvβ3 integrin blocking antibody (Ab). RT-PCR images are representative from two independent experiments. The ELISA values (mean ± standard deviation) are representative from two or three independent experiments ( n = 4). * p ≤ 0.05 using a Student’s t -test. The densitometric quantification values for phospho-IκB (p-IκB) immunoblot represent the ratio of phospho-IκB:actin and the fold-induction was calculated after normalizing with the control 0 min group. The densitometric values represent the mean ± standard deviation from three independent studies. * p ≤ 0.05 using a Student’s t -test

Journal: Nature Communications

Article Title: Integrin activation by the lipid molecule 25-hydroxycholesterol induces a proinflammatory response

doi: 10.1038/s41467-019-09453-x

Figure Lengend Snippet: α5β1 and αvβ3 integrins regulate 25HC-mediated proinflammatory response. a , c – g α5β1 and αvβ3 integrin-deficient cells were treated with 50 µM 25HC for 8 h to evaluate NFκB activation and proinflammatory response. a TNF secretion from 25HC-treated NR-9456 macrophages in the presence of either control IgG or α5β1 integrin blocking antibody (Ab). b Western blot analyses of α5 integrin protein expression in THP-1 cells transfected with either control siRNA (con siRNA) or α5 integrin-specific siRNA (α5 siRNA). c RT-PCR analyses of TNF expression in 25HC-treated THP-1 cells transfected with either control siRNA (con siRNA) or α5 integrin-specific siRNA (α5 siRNA). d Western blot and densitometric analyses of phospho-IκB status in 25HC-treated wild-type (WT) and α5 integrin knockout (KO) HAP1 cells. e TNF secretion from 25HC-treated WT and β3 integrin-deficient (β3 +/− cells) BMDMs. f , g TNF ( f ) and IL-6 ( g ) secretion from 25HC-treated THP-1 macrophages in the presence of either control IgG or αvβ3 integrin blocking antibody (Ab). RT-PCR images are representative from two independent experiments. The ELISA values (mean ± standard deviation) are representative from two or three independent experiments ( n = 4). * p ≤ 0.05 using a Student’s t -test. The densitometric quantification values for phospho-IκB (p-IκB) immunoblot represent the ratio of phospho-IκB:actin and the fold-induction was calculated after normalizing with the control 0 min group. The densitometric values represent the mean ± standard deviation from three independent studies. * p ≤ 0.05 using a Student’s t -test

Article Snippet: Purified human αvβ3 integrin protein (Yo proteins AB, Huddinge, Sweden) was covalently immobilized on a flow cell of CM5 chip (carboxy-methylated dextran coated) in 10 mM sodium acetate buffer, pH 4.0, using EDC/NHS amine coupling chemistry at 25 °C.

Techniques: Activation Assay, Blocking Assay, Western Blot, Expressing, Transfection, Reverse Transcription Polymerase Chain Reaction, Knock-Out, Enzyme-linked Immunosorbent Assay, Standard Deviation

The 25HC-integrin-FAK signaling network is required for optimal Nod2 response. a IL-6 in serum of mice injected (via intraperitoneal route) with 25HC (50 mg/kg; 4 h) ( n = 5). b , c , e , g – m Cells were treated with 25 µg/ml of MDP for 8 h and d , f mice were injected intraperitoneally with 20 mg/kg of MDP for 4 h. C25H expression, 25HC production, FAK activation, and proinflammatory response were assessed. b RT-PCR analyses of C25H expression in MDP-treated wild-type (WT) and C25H knockout (KO) BMDMs. c 25HC levels in the medium supernatant of MDP-treated BMDMs. d 25HC levels in the serum of WT mice treated with MDP ( n = 4). e IL-6 secretion from WT and C25H KO BMDMs treated with MDP. f IL-6 levels in the serum of WT and C25H KO mice treated with MDP ( n = 4). g Western blot and densitometric analyses of FAK activation (phospho-FAK, Tyr397) status in MDP-treated THP-1 macrophages. h IL-6 production from MDP-treated WT and FAK KO MEFs (mouse embryo fibroblasts). i IL-6 secretion from MDP-treated NR-9456 macrophages in the presence of either control IgG or α5β1 integrin blocking antibody (Ab). j RT-PCR analyses of TNF expression in MDP-treated THP-1 cells transfected with either control siRNA (con siRNA) or α5 integrin-specific siRNA (α5 siRNA). k TNF secretion from MDP-treated WT and β3 integrin-deficient (β3 +/− cells) BMDMs. l TNF secretion from MDP-treated THP-1 macrophages in the presence of either control IgG or αvβ3 integrin blocking antibody. m Western blot and densitometric analyses of FAK activation (phospho-FAK, Tyr925) status in MDP-treated WT and C25H KO BMDM. RT-PCR images are representative from two independent experiments. The ELISA values (mean ± standard deviation) are representative from two or three independent experiments ( n = 4). * p ≤ 0.05 using a Student’s t -test. The densitometric quantification values for phospho-FAK (p-FAK) immunoblot represent the ratio of phospho-FAK:actin and the fold-induction was calculated after normalizing with the control untreated (UT) group. The densitometric values represent the mean ± standard deviation from three independent studies. * p ≤ 0.05 using a Student’s t- test

Journal: Nature Communications

Article Title: Integrin activation by the lipid molecule 25-hydroxycholesterol induces a proinflammatory response

doi: 10.1038/s41467-019-09453-x

Figure Lengend Snippet: The 25HC-integrin-FAK signaling network is required for optimal Nod2 response. a IL-6 in serum of mice injected (via intraperitoneal route) with 25HC (50 mg/kg; 4 h) ( n = 5). b , c , e , g – m Cells were treated with 25 µg/ml of MDP for 8 h and d , f mice were injected intraperitoneally with 20 mg/kg of MDP for 4 h. C25H expression, 25HC production, FAK activation, and proinflammatory response were assessed. b RT-PCR analyses of C25H expression in MDP-treated wild-type (WT) and C25H knockout (KO) BMDMs. c 25HC levels in the medium supernatant of MDP-treated BMDMs. d 25HC levels in the serum of WT mice treated with MDP ( n = 4). e IL-6 secretion from WT and C25H KO BMDMs treated with MDP. f IL-6 levels in the serum of WT and C25H KO mice treated with MDP ( n = 4). g Western blot and densitometric analyses of FAK activation (phospho-FAK, Tyr397) status in MDP-treated THP-1 macrophages. h IL-6 production from MDP-treated WT and FAK KO MEFs (mouse embryo fibroblasts). i IL-6 secretion from MDP-treated NR-9456 macrophages in the presence of either control IgG or α5β1 integrin blocking antibody (Ab). j RT-PCR analyses of TNF expression in MDP-treated THP-1 cells transfected with either control siRNA (con siRNA) or α5 integrin-specific siRNA (α5 siRNA). k TNF secretion from MDP-treated WT and β3 integrin-deficient (β3 +/− cells) BMDMs. l TNF secretion from MDP-treated THP-1 macrophages in the presence of either control IgG or αvβ3 integrin blocking antibody. m Western blot and densitometric analyses of FAK activation (phospho-FAK, Tyr925) status in MDP-treated WT and C25H KO BMDM. RT-PCR images are representative from two independent experiments. The ELISA values (mean ± standard deviation) are representative from two or three independent experiments ( n = 4). * p ≤ 0.05 using a Student’s t -test. The densitometric quantification values for phospho-FAK (p-FAK) immunoblot represent the ratio of phospho-FAK:actin and the fold-induction was calculated after normalizing with the control untreated (UT) group. The densitometric values represent the mean ± standard deviation from three independent studies. * p ≤ 0.05 using a Student’s t- test

Article Snippet: Purified human αvβ3 integrin protein (Yo proteins AB, Huddinge, Sweden) was covalently immobilized on a flow cell of CM5 chip (carboxy-methylated dextran coated) in 10 mM sodium acetate buffer, pH 4.0, using EDC/NHS amine coupling chemistry at 25 °C.

Techniques: Injection, Expressing, Activation Assay, Reverse Transcription Polymerase Chain Reaction, Knock-Out, Western Blot, Blocking Assay, Transfection, Enzyme-linked Immunosorbent Assay, Standard Deviation

The 25HC-integrin-FAK signaling network regulates proinflammatory response during virus infection. a 25HC levels in the medium supernatant of BMDMs infected with human respiratory syncytial virus (RSV). b TNF production from wild-type (WT) and C25H knockout (KO) BMDMs infected with RSV. c Western blot and densitometric analyses of FAK activation (phospho-FAK, Tyr925) status in RSV-infected BMDMs. d Western blot and densitometric analyses of FAK activation (phospho-FAK, Tyr925) status in influenza A virus (IAV)-infected BMDMs. e IL-6 production from RSV-infected WT and FAK KO MEFs. f IL-6 production from IAV-infected WT and FAK KO MEFs. g TNF production from RSV-infected BMDMs in the presence of either control IgG or α5β1 integrin blocking antibody (Ab). h IL-6 production from IAV-infected BMDMs in the presence of either control IgG or α5β1 integrin blocking antibody. i TNF secretion from IAV-infected WT and β3 integrin-deficient (β3 +/− cells) BMDMs. j IL-6 secretion from IAV-infected THP-1 cells in the presence of either control IgG or αvβ3 integrin blocking antibody. k IL-6 in the lungs of mice injected (via intratracheal or I.T route) with 25HC (5 mg/kg; 6 h) in the presence of either IgG or β1 integrin blocking antibody (Ab) administered to the mice via I.T route ( n = 4). l IL-6 in the lungs of mice injected (via I.T route) with 25HC (5 mg/kg; 6 h) in the presence of either vehicle (control) or FAK inhibitor (PND-1186) administered to the mice via I.T route ( n = 4). The ELISA values (mean ± standard deviation) are representative from two or three independent experiments ( n = 4). * p ≤ 0.05 using a Student’s t -test. The densitometric quantification values for phospho-FAK (p-FAK) immunoblot represent the ratio of phospho-FAK:actin and the fold-induction was calculated after normalizing with the control mock-infected group. The densitometric values represent the mean ± standard deviation from three independent studies. * p ≤ 0.05 using a Student’s t -test

Journal: Nature Communications

Article Title: Integrin activation by the lipid molecule 25-hydroxycholesterol induces a proinflammatory response

doi: 10.1038/s41467-019-09453-x

Figure Lengend Snippet: The 25HC-integrin-FAK signaling network regulates proinflammatory response during virus infection. a 25HC levels in the medium supernatant of BMDMs infected with human respiratory syncytial virus (RSV). b TNF production from wild-type (WT) and C25H knockout (KO) BMDMs infected with RSV. c Western blot and densitometric analyses of FAK activation (phospho-FAK, Tyr925) status in RSV-infected BMDMs. d Western blot and densitometric analyses of FAK activation (phospho-FAK, Tyr925) status in influenza A virus (IAV)-infected BMDMs. e IL-6 production from RSV-infected WT and FAK KO MEFs. f IL-6 production from IAV-infected WT and FAK KO MEFs. g TNF production from RSV-infected BMDMs in the presence of either control IgG or α5β1 integrin blocking antibody (Ab). h IL-6 production from IAV-infected BMDMs in the presence of either control IgG or α5β1 integrin blocking antibody. i TNF secretion from IAV-infected WT and β3 integrin-deficient (β3 +/− cells) BMDMs. j IL-6 secretion from IAV-infected THP-1 cells in the presence of either control IgG or αvβ3 integrin blocking antibody. k IL-6 in the lungs of mice injected (via intratracheal or I.T route) with 25HC (5 mg/kg; 6 h) in the presence of either IgG or β1 integrin blocking antibody (Ab) administered to the mice via I.T route ( n = 4). l IL-6 in the lungs of mice injected (via I.T route) with 25HC (5 mg/kg; 6 h) in the presence of either vehicle (control) or FAK inhibitor (PND-1186) administered to the mice via I.T route ( n = 4). The ELISA values (mean ± standard deviation) are representative from two or three independent experiments ( n = 4). * p ≤ 0.05 using a Student’s t -test. The densitometric quantification values for phospho-FAK (p-FAK) immunoblot represent the ratio of phospho-FAK:actin and the fold-induction was calculated after normalizing with the control mock-infected group. The densitometric values represent the mean ± standard deviation from three independent studies. * p ≤ 0.05 using a Student’s t -test

Article Snippet: Purified human αvβ3 integrin protein (Yo proteins AB, Huddinge, Sweden) was covalently immobilized on a flow cell of CM5 chip (carboxy-methylated dextran coated) in 10 mM sodium acetate buffer, pH 4.0, using EDC/NHS amine coupling chemistry at 25 °C.

Techniques: Infection, Knock-Out, Western Blot, Activation Assay, Blocking Assay, Injection, Enzyme-linked Immunosorbent Assay, Standard Deviation

A schematic model showing regulation of proinflammatory response by 25HC-integrin-FAK signaling network. Nod2 activation and virus (RSV and IAV) infection triggers expression of C25H, which results in production of 25HC. Extracellular 25HC activates integrin-FAK-NFκB signaling. Thus, 25HC links PRR (Nod2) pathway with integrin-FAK-NFκB signaling to confer optimal proinflammatory response following Nod2 activation and virus infection. INTG, integrin; FAK, focal adhesion kinase

Journal: Nature Communications

Article Title: Integrin activation by the lipid molecule 25-hydroxycholesterol induces a proinflammatory response

doi: 10.1038/s41467-019-09453-x

Figure Lengend Snippet: A schematic model showing regulation of proinflammatory response by 25HC-integrin-FAK signaling network. Nod2 activation and virus (RSV and IAV) infection triggers expression of C25H, which results in production of 25HC. Extracellular 25HC activates integrin-FAK-NFκB signaling. Thus, 25HC links PRR (Nod2) pathway with integrin-FAK-NFκB signaling to confer optimal proinflammatory response following Nod2 activation and virus infection. INTG, integrin; FAK, focal adhesion kinase

Article Snippet: Purified human αvβ3 integrin protein (Yo proteins AB, Huddinge, Sweden) was covalently immobilized on a flow cell of CM5 chip (carboxy-methylated dextran coated) in 10 mM sodium acetate buffer, pH 4.0, using EDC/NHS amine coupling chemistry at 25 °C.

Techniques: Activation Assay, Infection, Expressing

Extracellular Matrix derived Endogenous angioinhibitors and their mode of action.

Journal: Pharmaceuticals

Article Title: Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix

doi: 10.3390/ph4121551

Figure Lengend Snippet: Extracellular Matrix derived Endogenous angioinhibitors and their mode of action.

Article Snippet: Prothrombin Kringle-2 , Prothrombin , αVβ3 integrin , Inhibits VEGF, MMP-2 and 9 expression, affects EC growth..

Techniques: Derivative Assay, Inhibition, Activation Assay, Binding Assay, Expressing

T3 induces ISG expression using non-genomic mechanisms involving integrin αVβ3 binding and activation of PLC–PI3K–AKT pathways. (a) HEK293FT cells were transfected with 1.5 µg of empty vector or cTHRα plasmid and protein extracts were processed for Western blot using Abs to THRα/β. Non-specific (NS) band is shown for equal loading. (b). HEK293FT cells were transfected with 1.0 μg of TATADR4-Luc in the presence or absence of 1.5 µg of empty vector or cTHRα plasmid. After 24 h of transfection, cells were treated with 75 µM T3 and harvested 16 h later for luciferase activity measurement. ** P < 0.01. NS: not significant. (c) HEK293FT cell were transfected with 1.0 µg of empty vector or cTHRα plasmid for 24 h. Cells were then treated with DMSO or 75 µM T3 for 16 h in the presence or absence of Poly IC. (d) 50 ng of IFIT-Promoter-Luc or 100 ng ISRE-Luc plasmids were transfected in HEK293FT cells followed by treatment with Poly IC in the presence or absence of DMSO or 75 µM T3. Cells were harvested and luciferase activity was measured. ** P < 0.01. (e) HEK293FT cells were treated with T3 (75 µM) or Poly IC either alone or in combination with each other in the presence of either DMSO or LY294002 (5 µM), U73122 (10 µM), or U0126 (5 µM) for 16 h. (f) HEK293FT cells were treated with T3 (75 µM) for indicated time periods. Proteins extracts were analyzed by Western blot using Abs to total AKT and phospho-AKT. (g) HEK293FT cells were treated for 16 h with DMSO or 75 µM T3 in the presence or absence of Poly IC and 50 µg/ml RGD peptide or a control peptide. RNA was isolated from the cell pellets (c, e, and g) and the expression of IFIT3 quantitated by real-time RT-PCR as described in the Methods section. All the data presented are in comparison to DMSO control groups. ** P < 0.01. NS: not significant.

Journal: Innate Immunity

Article Title: RNA-activated protein kinase differentially modulates innate immune response mediated by supraphysiological concentrations of thyroid hormone

doi: 10.1177/1753425920955214

Figure Lengend Snippet: T3 induces ISG expression using non-genomic mechanisms involving integrin αVβ3 binding and activation of PLC–PI3K–AKT pathways. (a) HEK293FT cells were transfected with 1.5 µg of empty vector or cTHRα plasmid and protein extracts were processed for Western blot using Abs to THRα/β. Non-specific (NS) band is shown for equal loading. (b). HEK293FT cells were transfected with 1.0 μg of TATADR4-Luc in the presence or absence of 1.5 µg of empty vector or cTHRα plasmid. After 24 h of transfection, cells were treated with 75 µM T3 and harvested 16 h later for luciferase activity measurement. ** P < 0.01. NS: not significant. (c) HEK293FT cell were transfected with 1.0 µg of empty vector or cTHRα plasmid for 24 h. Cells were then treated with DMSO or 75 µM T3 for 16 h in the presence or absence of Poly IC. (d) 50 ng of IFIT-Promoter-Luc or 100 ng ISRE-Luc plasmids were transfected in HEK293FT cells followed by treatment with Poly IC in the presence or absence of DMSO or 75 µM T3. Cells were harvested and luciferase activity was measured. ** P < 0.01. (e) HEK293FT cells were treated with T3 (75 µM) or Poly IC either alone or in combination with each other in the presence of either DMSO or LY294002 (5 µM), U73122 (10 µM), or U0126 (5 µM) for 16 h. (f) HEK293FT cells were treated with T3 (75 µM) for indicated time periods. Proteins extracts were analyzed by Western blot using Abs to total AKT and phospho-AKT. (g) HEK293FT cells were treated for 16 h with DMSO or 75 µM T3 in the presence or absence of Poly IC and 50 µg/ml RGD peptide or a control peptide. RNA was isolated from the cell pellets (c, e, and g) and the expression of IFIT3 quantitated by real-time RT-PCR as described in the Methods section. All the data presented are in comparison to DMSO control groups. ** P < 0.01. NS: not significant.

Article Snippet: Cyclo (RGDfC) αVβ3 integrin-binding peptide (RGD) and Cyclo (-RADfK-), RGD negative control peptide, were obtained from Anaspec (Fermont, CA).

Techniques: Expressing, Binding Assay, Activation Assay, Transfection, Plasmid Preparation, Western Blot, Luciferase, Activity Assay, Control, Isolation, Quantitative RT-PCR, Comparison

Integrin αVβ3 is upregulated in OPLL. a Typical preoperative CT and image of a patient with cervical OPLL (the red square at the left indicates OPLL of the cervical spine) and postoperative X-ray image indicating anterior en bloc resection of the cervical ossified posterior longitudinal ligament (the blue square at the right). b RNA-seq visualized by heatmap analysis. c GSEA plots illustrating upregulation of ECM receptor signaling pathway in LFs derived from patients with OPLL and non-OPLL. d Integrin subfamily molecule expression levels using the RNA-seq sequencing results visualized by heatmap analysis. e Relative mRNA expression levels of Integrin subfamily molecule. f The expression of integrin αVβ3 was detected by western blot. g HE staining, immunohistochemical analysis of OCN and integrin αVβ3, and immunofluorescence analysis of CD31 in ligament tissues from patients with OPLL and non-OPLL patients. h Quantitative analysis of OCN-positive cells in g. n = 3 per group. i Quantitative analysis of integrin αVβ3-positive cells in g. n = 3 per group. j Quantitative analysis of CD31-positive cells in g, n = 3 per group. k Quantitative analysis of integrin αVβ3 by western blot. n = 3 per group. All experimental data are presented as the mean value ± SD. Student’s t-test used in ( h ), ( i ), ( j ), and ( k ). * p < 0.05, ** p < 0.01, *** p < 0.001

Journal: Molecular Medicine

Article Title: Integrin αVβ3 antagonist-c(RGDyk) peptide attenuates the progression of ossification of the posterior longitudinal ligament by inhibiting osteogenesis and angiogenesis

doi: 10.1186/s10020-024-00822-x

Figure Lengend Snippet: Integrin αVβ3 is upregulated in OPLL. a Typical preoperative CT and image of a patient with cervical OPLL (the red square at the left indicates OPLL of the cervical spine) and postoperative X-ray image indicating anterior en bloc resection of the cervical ossified posterior longitudinal ligament (the blue square at the right). b RNA-seq visualized by heatmap analysis. c GSEA plots illustrating upregulation of ECM receptor signaling pathway in LFs derived from patients with OPLL and non-OPLL. d Integrin subfamily molecule expression levels using the RNA-seq sequencing results visualized by heatmap analysis. e Relative mRNA expression levels of Integrin subfamily molecule. f The expression of integrin αVβ3 was detected by western blot. g HE staining, immunohistochemical analysis of OCN and integrin αVβ3, and immunofluorescence analysis of CD31 in ligament tissues from patients with OPLL and non-OPLL patients. h Quantitative analysis of OCN-positive cells in g. n = 3 per group. i Quantitative analysis of integrin αVβ3-positive cells in g. n = 3 per group. j Quantitative analysis of CD31-positive cells in g, n = 3 per group. k Quantitative analysis of integrin αVβ3 by western blot. n = 3 per group. All experimental data are presented as the mean value ± SD. Student’s t-test used in ( h ), ( i ), ( j ), and ( k ). * p < 0.05, ** p < 0.01, *** p < 0.001

Article Snippet: Integrin αVβ3 is involved in vascular lumen formation and vascular network construction by regulating the adhesion and migration of EC in angiogenesis(Rocha et al. ).

Techniques: RNA Sequencing, Derivative Assay, Expressing, Sequencing, Western Blot, Staining, Immunohistochemical staining, Immunofluorescence

The c(RGDyk) peptide effectively inhibits the expression of integrin αVβ3 in LFs and ECs. a Cell proliferation of LFs when cultured with different concentrations of C(RGDyk) peptide. b Immunofluorescence of phalloidin and integrin αVβ3 in LFs. Scale bar:100 μm. c Quantitative analysis of integrin αVβ3 fluorescence intensity in LFs. d Cell proliferation of ECs when cultured with different concentrations of c(RGDyk) peptide. e Immunofluorescence of phalloidin and integrin αVβ3 in ECs. Scale bar:100 μm. f Quantitative analysis of integrin αVβ3 fluorescence intensity in ECs. All experiments were repeated three times. All experimental data are presented as the mean value ± SD. One-way ANOVA for multiple comparisons is used in ( a ), ( c ), ( e ), and ( f ). * p < 0.05, ** p < 0.01, *** p < 0.001

Journal: Molecular Medicine

Article Title: Integrin αVβ3 antagonist-c(RGDyk) peptide attenuates the progression of ossification of the posterior longitudinal ligament by inhibiting osteogenesis and angiogenesis

doi: 10.1186/s10020-024-00822-x

Figure Lengend Snippet: The c(RGDyk) peptide effectively inhibits the expression of integrin αVβ3 in LFs and ECs. a Cell proliferation of LFs when cultured with different concentrations of C(RGDyk) peptide. b Immunofluorescence of phalloidin and integrin αVβ3 in LFs. Scale bar:100 μm. c Quantitative analysis of integrin αVβ3 fluorescence intensity in LFs. d Cell proliferation of ECs when cultured with different concentrations of c(RGDyk) peptide. e Immunofluorescence of phalloidin and integrin αVβ3 in ECs. Scale bar:100 μm. f Quantitative analysis of integrin αVβ3 fluorescence intensity in ECs. All experiments were repeated three times. All experimental data are presented as the mean value ± SD. One-way ANOVA for multiple comparisons is used in ( a ), ( c ), ( e ), and ( f ). * p < 0.05, ** p < 0.01, *** p < 0.001

Article Snippet: Integrin αVβ3 is involved in vascular lumen formation and vascular network construction by regulating the adhesion and migration of EC in angiogenesis(Rocha et al. ).

Techniques: Expressing, Cell Culture, Immunofluorescence, Fluorescence

The c(RGDyk) peptide inhibits osteogenesis and angiogenesis by targeting integrin αVβ3 and regulating the FAK/ERK1/2 pathway. a and b Western blotting and quantitative analysis of the protein expression of the FAK/ERK1/2 pathway in ECs, including integrin αVβ3, p-VEGFR2, p-FAK, FAK, p-ERK1/2, and ERK1/2. c and d Western blotting and quantitative analysis of the protein expression of the FAK/ERK1/2 pathway in LFs, including integrin αVβ3, p-FAK, FAK, p-ERK1/2, ERK1/2, and RUNX2. β-actin was selected as the internal control. All experiments were repeated three times. All experimental data are presented as the mean value ± SD. One-way ANOVA for multiple comparisons is used in ( b ) and ( d ). * p < 0.05, ** p < 0.01, *** p < 0.001

Journal: Molecular Medicine

Article Title: Integrin αVβ3 antagonist-c(RGDyk) peptide attenuates the progression of ossification of the posterior longitudinal ligament by inhibiting osteogenesis and angiogenesis

doi: 10.1186/s10020-024-00822-x

Figure Lengend Snippet: The c(RGDyk) peptide inhibits osteogenesis and angiogenesis by targeting integrin αVβ3 and regulating the FAK/ERK1/2 pathway. a and b Western blotting and quantitative analysis of the protein expression of the FAK/ERK1/2 pathway in ECs, including integrin αVβ3, p-VEGFR2, p-FAK, FAK, p-ERK1/2, and ERK1/2. c and d Western blotting and quantitative analysis of the protein expression of the FAK/ERK1/2 pathway in LFs, including integrin αVβ3, p-FAK, FAK, p-ERK1/2, ERK1/2, and RUNX2. β-actin was selected as the internal control. All experiments were repeated three times. All experimental data are presented as the mean value ± SD. One-way ANOVA for multiple comparisons is used in ( b ) and ( d ). * p < 0.05, ** p < 0.01, *** p < 0.001

Article Snippet: Integrin αVβ3 is involved in vascular lumen formation and vascular network construction by regulating the adhesion and migration of EC in angiogenesis(Rocha et al. ).

Techniques: Western Blot, Expressing, Control

c(RGDyk) peptide inhibits heterotopic bone formation in vivo. a The procedures of the heterotopic bone formation assay in vivo. LFs were treated with c(RGDyk) peptide before implantation. b Representative 3D-reconstructed micro-CT images of a scaffold implanted in coculture with LFs after 8 weeks. c Micro-CT scan analysis of the BV/TV and BMD of scaffolds among different groups ( n = 3). d HE staining, immunohistochemical analysis of OCN and integrin αVβ3, and immunofluorescence analysis of CD31 among different implanted scaffolds. e Quantitative analysis of OCN-positive, integrin αVβ3-positive, and CD31-positive cells in d. n = 3 per group. All experimental data are presented as the mean value ± SD. One-way ANOVA for multiple comparisons is used in ( c ) and ( e ). * p < 0.05, ** p < 0.01, *** p < 0.001

Journal: Molecular Medicine

Article Title: Integrin αVβ3 antagonist-c(RGDyk) peptide attenuates the progression of ossification of the posterior longitudinal ligament by inhibiting osteogenesis and angiogenesis

doi: 10.1186/s10020-024-00822-x

Figure Lengend Snippet: c(RGDyk) peptide inhibits heterotopic bone formation in vivo. a The procedures of the heterotopic bone formation assay in vivo. LFs were treated with c(RGDyk) peptide before implantation. b Representative 3D-reconstructed micro-CT images of a scaffold implanted in coculture with LFs after 8 weeks. c Micro-CT scan analysis of the BV/TV and BMD of scaffolds among different groups ( n = 3). d HE staining, immunohistochemical analysis of OCN and integrin αVβ3, and immunofluorescence analysis of CD31 among different implanted scaffolds. e Quantitative analysis of OCN-positive, integrin αVβ3-positive, and CD31-positive cells in d. n = 3 per group. All experimental data are presented as the mean value ± SD. One-way ANOVA for multiple comparisons is used in ( c ) and ( e ). * p < 0.05, ** p < 0.01, *** p < 0.001

Article Snippet: Integrin αVβ3 is involved in vascular lumen formation and vascular network construction by regulating the adhesion and migration of EC in angiogenesis(Rocha et al. ).

Techniques: In Vivo, Tube Formation Assay, Micro-CT, Staining, Immunohistochemical staining, Immunofluorescence

Schematic diagram of the mechanism by which c(RGDyk) suppressed integrin αVβ3 to inhibit OPLL

Journal: Molecular Medicine

Article Title: Integrin αVβ3 antagonist-c(RGDyk) peptide attenuates the progression of ossification of the posterior longitudinal ligament by inhibiting osteogenesis and angiogenesis

doi: 10.1186/s10020-024-00822-x

Figure Lengend Snippet: Schematic diagram of the mechanism by which c(RGDyk) suppressed integrin αVβ3 to inhibit OPLL

Article Snippet: Integrin αVβ3 is involved in vascular lumen formation and vascular network construction by regulating the adhesion and migration of EC in angiogenesis(Rocha et al. ).

Techniques: